Free Trial

Consolidated Planning Corp Boosts Stock Position in Cabot Corporation (NYSE:CBT)

Cabot logo with Basic Materials background

Consolidated Planning Corp raised its position in Cabot Corporation (NYSE:CBT - Free Report) by 80.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,431 shares of the specialty chemicals company's stock after purchasing an additional 4,204 shares during the quarter. Consolidated Planning Corp's holdings in Cabot were worth $784,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Delta Financial Group Inc. acquired a new stake in shares of Cabot in the fourth quarter valued at $274,000. JPMorgan Chase & Co. lifted its stake in Cabot by 27.1% during the 4th quarter. JPMorgan Chase & Co. now owns 451,513 shares of the specialty chemicals company's stock worth $41,228,000 after acquiring an additional 96,179 shares in the last quarter. SG Americas Securities LLC purchased a new position in Cabot during the 1st quarter valued at about $1,102,000. QRG Capital Management Inc. acquired a new position in Cabot in the 1st quarter valued at about $482,000. Finally, Dorsey Wright & Associates acquired a new position in Cabot in the 4th quarter valued at about $3,201,000. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Stock Up 1.8%

NYSE:CBT traded up $1.34 during midday trading on Thursday, reaching $76.42. The company had a trading volume of 428,106 shares, compared to its average volume of 410,785. The firm has a market capitalization of $4.11 billion, a price-to-earnings ratio of 9.89, a PEG ratio of 0.68 and a beta of 0.87. The stock's fifty day simple moving average is $75.76 and its 200-day simple moving average is $83.07. Cabot Corporation has a 12-month low of $71.64 and a 12-month high of $117.46. The company has a current ratio of 1.96, a quick ratio of 1.30 and a debt-to-equity ratio of 0.69.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.86 by $0.04. The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $1.02 billion. Cabot had a return on equity of 26.76% and a net margin of 11.08%. Cabot's revenue for the quarter was down 8.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 EPS. On average, sell-side analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 30th were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 30th. This represents a $1.80 dividend on an annualized basis and a yield of 2.36%. This is an increase from Cabot's previous quarterly dividend of $0.43. Cabot's payout ratio is currently 23.29%.

Wall Street Analysts Forecast Growth

CBT has been the topic of several research reports. Wall Street Zen cut shares of Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. UBS Group cut their target price on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th.

Read Our Latest Stock Analysis on CBT

Cabot Company Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines